Yu Mei Wu
Overview
Explore the profile of Yu Mei Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He Y, Han S, Geng Y, Yang S, Wu Y
J Gynecol Oncol
. 2020 Jan;
31(3):e28.
PMID: 31912682
Objective: This study aimed to identify proteins related to paclitaxel and carboplatin chemoresistance in cervical cancer. Methods: Quantitative proteomic analysis was performed on normal SiHa cells and those treated with...
2.
Yang S, Wu Y, Zhang B, Zhang Y, Fan W, Jin S, et al.
Ying Yong Sheng Tai Xue Bao
. 2018 May;
28(1):281-290.
PMID: 29749213
A thermocline characteristics contour on a spatial overlay map was plotted using data collected on a monthly basis from Argo buoys and data of monthly CPUE (catch per unit effort)...
3.
Xiao L, Wu Y, Qian J, Tan Y, Xie G, Zhang K, et al.
Cancer Biol Ther
. 2010 Jun;
10(3):242-50.
PMID: 20574150
Background: IL-24 (interleukin-24) is a promising, multi-functional anti-cancer agent able to selectively induce tumor cell apoptosis while sparing normal cells. Additionally, IL-24 can enhance the immune response to tumors and...
4.
Zhang K, Wang Y, Cao X, Zhong S, Wei R, Wu Y, et al.
Hum Gene Ther
. 2009 Mar;
20(8):818-30.
PMID: 19320563
Interleukin (IL)-24 is an excellent therapeutic gene for cancer therapy. In this work, IL-24 was inserted into Ad.sp-E1A(Delta24), an oncolytic adenovirus with a 24-bp deletion in the E1A gene, which...